Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Fan YM et al. The effect of edible black tree fungus (Auricuaria auricula) on experimental atherosclerosis in rabbits. 1989 Chin. Med. J. pmid:2505974
Gao F et al. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. 2011 Chin. Med. J. pmid:21740787
Liu FM and Xu SC Effect of captopril cardioplegia on renin-angiotensin system, prostaglandins, free radicals and electrolytes in the isolated hypothermic ischemic and reperfusion rabbit hearts. 1993 Chin. Med. J. pmid:8143507
Chen SY et al. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus. 1990 Chin. Med. J. pmid:2167823
Wang Z et al. Changes of vasoactive polypeptides during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage. 2007 Chin. Med. J. pmid:18167188
He LZ and Lu LH Hypercoagulable state and hemorrhage in acute leukemias. 1988 Chin. Med. J. pmid:3146479
Yang CS and Zhang LZ Prostacyclin and thromboxane in pregnancy-induced hypertension. 1988 Chin. Med. J. pmid:3150739
Wu F et al. Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension. 2015 Chin. Med. J. pmid:25591555
Zhao HY and Fang WY Antithrombotic effects of Andrographis paniculata nees in preventing myocardial infarction. 1991 Chin. Med. J. pmid:1935360
Ji Y et al. Thrombosis and its significance after experimental pulmonary thromboembolism. 2003 Chin. Med. J. pmid:12667387
Wu S and Weng X Regulation of atrial natriuretic peptide, thromboxane and prostaglandin production by androgen in elderly men with coronary heart disease. 1993 Chin. Med. Sci. J. pmid:8032065
Xiao X et al. Effect of captopril on renal hemodynamics and renal prostaglandins in early type II diabetic patients with normo-or microalbuminuria. 1996 Chin. Med. Sci. J. pmid:9387403
Lin Y Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase. 1995 Chin. Med. Sci. J. pmid:8580482
Hayball PJ et al. Enantioselective pharmacodynamics of the nonsteroidal antiinflammatory drug ketoprofen: in vitro inhibition of human platelet cyclooxygenase activity. 1992 Chirality pmid:1476858
Landoni MF and Lees P Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves. 1995 Chirality pmid:8593252
Butler BD et al. Circadian study of decompression sickness symptoms and response-associated variables in rats. 2010 Chronobiol. Int. pmid:20205563
Capodanno D et al. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. 2011 Circ Cardiovasc Interv pmid:21386092
Basili S et al. Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes. 2014 Circ Cardiovasc Interv pmid:25074252
Nakamura A et al. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. 2013 Circ. J. pmid:23676973
DeFilippis AP et al. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. 2013 Circ. J. pmid:23985963
Watanabe H et al. Effects of salt loading on blood pressure in mice lacking the prostanoid receptor gene. 2005 Circ. J. pmid:15635218
Santilli F et al. Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. 2016 Circ. J. pmid:26632534
Friedman LS et al. Cardiovascular and pulmonary effects of thromboxane B2 in the dog. 1979 Circ. Res. pmid:428069
Wise WC et al. Protective effects of thromboxane synthetase inhibitors in rats in endotoxic shock. 1980 Circ. Res. pmid:7189697
Zhou Y et al. Increased expression of cyclooxygenase-2 mediates enhanced contraction to endothelin ETA receptor stimulation in endothelial nitric oxide synthase knockout mice. 2006 Circ. Res. pmid:16645140
Townsend ER et al. Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone. 1981 Circ. Res. pmid:7249281
Seeger W et al. Pulmonary vasoconstrictor response to soluble fibrin in isolated lungs: possible role of thromboxane generation. 1988 Circ. Res. pmid:3349571
Fitzgerald DJ et al. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo. 1989 Circ. Res. pmid:2500270
Morel DR et al. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation. 1988 Circ. Res. pmid:3129208
Ito BR et al. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation. 1989 Circ. Res. pmid:2509096
Malik KU Prostaglandin-mediated inhibition of the vasoconstrictor responses of the isolated perfused art splenic vasculature to adrenergic stimuli. 1978 Circ. Res. pmid:27321
Michael LH et al. Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion. 1990 Circ. Res. pmid:2317886
Freedman JE et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. 1999 Circ. Res. pmid:10381894
Lefer AM et al. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium. 1988 Circ. Res. pmid:3136950
Schmitz JM et al. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. 1985 Circ. Res. pmid:3926340
Rabinovici R et al. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. 1991 Circ. Res. pmid:1647275
Torsney E et al. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. 2004 Circ. Res. pmid:15117816
Horgan MJ et al. Mechanism of endothelin-1-induced pulmonary vasoconstriction. 1991 Circ. Res. pmid:2054931
Grigorian GY and Ryan US Platelet-activating factor effects on bovine pulmonary artery endothelial cells. 1987 Circ. Res. pmid:3040294
McDonald JW et al. Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep. 1983 Circ. Res. pmid:6687354
Biaggioni I et al. Adenosine produces pulmonary vasoconstriction in sheep. Evidence for thromboxane A2/prostaglandin endoperoxide-receptor activation. 1989 Circ. Res. pmid:2582587
Chemtob S et al. Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure. Cerebral blood flow autoregulation of the newborn. 1990 Circ. Res. pmid:2397575
Michael LH et al. Myocardial ischemia: platelet and thromboxane concentrations in cardiac lymph and the effects of ibuprofen and prostacyclin. 1986 Circ. Res. pmid:3524894
Rabinovici R et al. Interleukin-2-induced lung injury. The role of complement. 1994 Circ. Res. pmid:8293571
Kleinbongard P et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. 2011 Circ. Res. pmid:21183739
Armstead WM et al. Vascular responses to vasopressin are tone-dependent in the cerebral circulation of the newborn pig. 1989 Circ. Res. pmid:2909297
Purchase M et al. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart. 1986 Circ. Res. pmid:3080260
Hüttemeier PC et al. Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep. 1982 Circ. Res. pmid:7042108
Goldman G et al. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. 1991 Circ. Res. pmid:1672629
Leffler CW and Busija DW Prostanoids in cortical subarachnoid cerebrospinal fluid and pial arterial diameter in newborn pigs. 1985 Circ. Res. pmid:4053302
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286
Camporesi EM et al. Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboons. 1989 Circ. Shock pmid:2686855
Redl H et al. TNF- and LPS-induced changes of lung vascular permeability: studies in unanesthetised sheep. 1990 Circ. Shock pmid:2344658
Sturniolo R et al. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats. 1989 Circ. Shock pmid:2766481
Watt GH et al. Alterations in plasma levels and complexing of Gc (vitamin D-binding protein) in rats with endotoxic shock. 1989 Circ. Shock pmid:2766482
Hock CE and Lefer AM Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock. 1984 Circ. Shock pmid:6542462
Traber LD et al. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model. 1992 Circ. Shock pmid:1374688
Krausz MM et al. Effect of the leukotriene receptor antagonist LY-171883 on endotoxemia in awake sheep. 1988 Circ. Shock pmid:2850874
Cook JA et al. Sensitization of essential fatty acid-deficient rats to endotoxin by arachidonate pretreatment: role of thromboxane A2. 1981 Circ. Shock pmid:7237685
Slotman GJ et al. Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. 1985 Circ. Shock pmid:3915237
Rabinovici R et al. Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist. 1990 Circ. Shock pmid:2397568
Li JX et al. Age-related differences in responses to endotoxin infusion in unanesthetized piglets. 1993 Circ. Shock pmid:8403245
Bottoms GD et al. Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils. 1985 Circ. Shock pmid:3919961
McKechnie K et al. Metabolic and cardiovascular effects of endotoxin infusion in conscious unrestrained rats: effects of methylprednisolone and BW755C. 1985 Circ. Shock pmid:3919962
Kaszaki J et al. Humoral changes in shock induced by cardiac tamponade. 1989 Circ. Shock pmid:2684445
Izumi T and Bakhle YS Output of prostanoids from rat lung following endotoxin and its modification by methylprednisolone. 1989 Circ. Shock pmid:2731323
Redl H et al. Cardiovascular reaction pattern during endotoxin or peptidoglycan application in awake sheep. 1989 Circ. Shock pmid:2736725
Koch T et al. Influence of a pentoxifylline-analogue on the granulocyte-mediated pulmonary mediator release and vascular reaction. 1993 Circ. Shock pmid:7685249
Oei HH et al. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock. 1986 Circ. Shock pmid:3753907
Rabinovici R et al. Characterization of hemodynamic, hematologic, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. 1989 Circ. Shock pmid:2582582
Bottoms GD et al. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187. 1986 Circ. Shock pmid:3094976
Traber DL et al. The pulmonary lesion of smoke inhalation in an ovine model. 1986 Circ. Shock pmid:2421939
Wright RM et al. Lipopolysaccharide induces interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a novel mechanism. 1993 Circ. Shock pmid:7505726
Rabinovici R et al. Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. 1992 Circ. Shock pmid:1511503
Morris DD and Moore JN Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441. 1989 Circ. Shock pmid:2544315
Cook JA et al. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia. 1985 Circ. Shock pmid:3978769
Krausz MM et al. Effect of hemorrhagic hypotension on endotoxin-induced lung injury in awake sheep. 1989 Circ. Shock pmid:2917372
Dunn CW and Horton JW Role of angiotensin II in neonatal sepsis. 1993 Circ. Shock pmid:8508519
Semrad SD et al. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves. 1993 Circ. Shock pmid:8375024
Barton MH and Moore JN Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. 1994 Circ. Shock pmid:7628064
Templeton CB et al. Effects of repeated endotoxin injections on prostanoids, hemodynamics, endothelial cells, and survival in ponies. 1985 Circ. Shock pmid:3840414
Fink MP et al. Plasma levels of 6-keto PGF1 alpha but not TxB2 increase in rats with peritonitis due to cecal ligation. 1985 Circ. Shock pmid:3840415
Wise WC et al. Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock. 1985 Circ. Shock pmid:3840416
Demling RH et al. Role of subcutaneous tissue endotoxin in the production of prostanoid-induced lung injury: comparison with intravenous endotoxin response. 1985 Circ. Shock pmid:3840417
Pittet JF and Morel DR Imbalance between plasma levels of thromboxane B2 and 6-keto-prostaglandin F1 alpha during subacute endotoxin-induced hyperdynamic sepsis or multiple organ failure syndrome in sheep. 1991 Circ. Shock pmid:1777948
Feuerstein G et al. Effects of nafazatrom on cardiovascular, sympathetic, and endocrine responses to hemorrhagic shock in conscious rats. 1985 Circ. Shock pmid:3841032
Rinaldo JE and Dauber JH Effect of methylprednisolone and of ibuprofen, a nonsteroidal antiinflammatory agent, on bronchoalveolar inflammation following endotoxemia. 1985 Circ. Shock pmid:4053294
Schützer KM et al. Cardiopulmonary function as related to thromboxane A2 synthesis in experimental septic shock. 1988 Circ. Shock pmid:3056632
Harvey CF et al. Ibuprofen and methylprednisolone in a pig Pseudomonas ARDS model. 1987 Circ. Shock pmid:3568279
Heard SO et al. Dietary enrichment with omega-3 fatty acids partially protects against lipopolysaccharide-induced atrial depression in rats. 1992 Circ. Shock pmid:1582005
Reilly IA et al. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. 1986 Circulation pmid:2938849
Fuse S and Kamiya T Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease. 1994 Circulation pmid:7994842
Théroux P et al. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. 1987 Circulation pmid:2947740
de Boer AC et al. Platelet release and thromboxane synthesis in symptomatic coronary artery disease. 1982 Circulation pmid:6212161
Mehta J and Mehta P Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. 1982 Circulation pmid:6216027
Fischer S et al. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man. 1983 Circulation pmid:6352080
Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT). 1994 Circulation pmid:8313547
Grande P et al. Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. 1990 Circulation pmid:2136815
Gershlick AH Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically? 1990 Circulation pmid:2136816
Cattaneo M Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk". 2009 Circulation pmid:19546394